CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Short Interest Down 63.6% in December

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 2,538 shares, a drop of 63.6% from the November 30th total of 6,974 shares. Based on an average daily volume of 33,732 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company's stock are sold short. Approximately 0.0% of the company's stock are sold short. Based on an average daily volume of 33,732 shares, the short-interest ratio is currently 0.1 days.Analyst Ratings ChangesCHEOY has been the subject of a number of analyst reports. Canaccord Genuity Group raised CochLear from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, October 7th. Citigroup cut CochLear to a "neutral" rating in a research note on Thursday, September 18th. Two analysts have rated the stock with a Strong Buy rating and three have given a Hold rating to the company. According to MarketBeat, CochLear currently has a consensus rating of "Moderate Buy".Read Our Latest Stock Report on CochLearCochLear Trading Up 0.5%Shares of CHEOY opened at $88.01 on Friday. The business's fifty day simple moving average is $90.51 and its two-hundred day simple moving average is $94.86. CochLear has a 12 month low of $74.76 and a 12 month high of $105.60. About CochLear (Get Free Report)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia. Read MoreFive stocks we like better than CochLearWashington prepares for warTurn your "dead money" into $306+ monthly (starting this month)$100 Trillion “AI Metal” Found in American Ghost TownPut $1,000 into this stock by Jan 1 [Not NVDA]Terrifying reason Trump killed the U.S. penny?This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in CochLear Right Now?Before you consider CochLear, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here